HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y-S Lee Selected Research

Therapeutics

11/2016Effect of stress hyperglycemia and intensive rehabilitation therapy in non-diabetic hemorrhagic stroke: Korean Stroke Cohort for Functioning and Rehabilitation.
12/2014Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy.
3/2012Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome.
9/2011Symptom change after discontinuation of successful antimuscarinic treatment in patients with overactive bladder symptoms: a randomised, multicentre trial.
8/2011Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest.
1/2011eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer.
11/2004Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.
6/2004Molecular genetic and proteomic analysis of synchronous malignant gliomas.
3/2002Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y-S Lee Research Topics

Disease

12Neoplasms (Cancer)
03/2016 - 06/2004
5Carcinogenesis
12/2017 - 06/2004
4Insulin Resistance
01/2022 - 08/2011
4Infections
01/2017 - 06/2005
4Overactive Urinary Bladder (Overactive Bladder)
11/2015 - 09/2011
3Inflammation (Inflammations)
09/2012 - 10/2004
2Hyperglycemia
01/2022 - 11/2016
2Erectile Dysfunction
05/2014 - 12/2003
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2012 - 03/2010
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2010 - 11/2004
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2005 - 07/2005
1Sleepiness
01/2023
1Cognitive Dysfunction
01/2020
1Refractive Errors (Refractive Error)
01/2018
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2018
1Ganglion Cysts (Ganglion)
01/2018
1Glaucoma
01/2018
1Hepatitis B
01/2017
1Chronic Hepatitis B
01/2017
1Hemorrhagic Stroke
11/2016
1Stroke (Strokes)
11/2016
1Drug Resistant Epilepsy
04/2016
1Epilepsy (Aura)
04/2016
1Hearing Loss (Hearing Impairment)
01/2016
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2016
1Bone Resorption
08/2015
1Neck Pain (Cervicalgia)
04/2015
1Chromosome Aberrations (Chromosome Abnormalities)
12/2014
1Coinfection
10/2014
1Flank Pain
08/2014
1Bacteremia
08/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2014
1Neutropenia
10/2013
1Diarrhea
10/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2013
1Hematoma
08/2013
1Edema (Dropsy)
08/2013
1Cerebral Hemorrhage
08/2013
1Autoimmune Diseases (Autoimmune Disease)
06/2013

Drug/Important Bio-Agent (IBA)

4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2003
4EnzymesIBA
03/2016 - 07/2006
4Proteins (Proteins, Gene)FDA Link
04/2014 - 06/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 10/2004
3Muscarinic AntagonistsIBA
12/2014 - 09/2011
3Small Interfering RNA (siRNA)IBA
01/2011 - 05/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2016
2CytokinesIBA
10/2014 - 04/2008
2Phosphodiesterase 5 InhibitorsIBA
05/2014 - 12/2003
2Transcription Factors (Transcription Factor)IBA
04/2014 - 06/2010
2Irinotecan (Camptosar)FDA LinkGeneric
02/2014 - 10/2013
2LipopolysaccharidesIBA
09/2012 - 08/2006
2ElementsIBA
08/2011 - 05/2009
2IsoflavonesIBA
08/2011 - 12/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2008 - 10/2004
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2005 - 11/2004
2fludarabineIBA
10/2003 - 08/2003
2Busulfan (Busulfex)FDA Link
10/2003 - 08/2003
1NitritesIBA
01/2022
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Retinaldehyde (Retinal)IBA
01/2018
1RNA Polymerase IIIIBA
12/2017
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
01/2017
1Tenofovir (Viread)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
04/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2016
1Verapamil (Calan)FDA LinkGeneric
04/2016
1Ligases (Synthetase)IBA
03/2016
1SulfurIBA
03/2016
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2016
1EscitalopramFDA Link
01/2016
13- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA
01/2016
1Cholinergic Antagonists (Anticholinergics)IBA
11/2015
1Psychosine (Galactosylsphingosine)IBA
08/2015
1LigandsIBA
08/2015
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2015
1Differentiation AntigensIBA
08/2015
1Tamsulosin (Flomax)FDA LinkGeneric
12/2014
1NucleotidesIBA
12/2014
1Solifenacin SuccinateFDA Link
12/2014
1Immunoglobulin A (IgA)IBA
10/2014
1Immunoglobulin G (IgG)IBA
10/2014
1AntibodiesIBA
10/2014
1ImmunosorbentsIBA
10/2014
1ProcalcitoninIBA
08/2014
1C-Reactive ProteinIBA
08/2014
1Cisplatin (Platino)FDA LinkGeneric
02/2014
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2013
1Celecoxib (Celebrex)FDA Link
08/2013

Therapy/Procedure

9Therapeutics
11/2016 - 03/2002
5Drug Therapy (Chemotherapy)
02/2014 - 11/2004
3Cell Transplantation
03/2012 - 10/2003
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2005 - 11/2004
1Nasal Surgical Procedures
01/2023
1Lenses
01/2018
1Intravenous Infusions
04/2016
1Thyroidectomy
04/2015
1Transcutaneous Electric Nerve Stimulation (TENS)
04/2015
1Organ Transplantation
06/2013